Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences

Journal of Cancer Education

Volumn 31, Issue 3, 2016, Pages 443-448

  Oostendorp, Linda J M ^a   Ottevanger, Petronella B ^a   van de Wouw, Agnes J ^b   Honkoop, Aafke H ^c   Los, Maartje ^d   van der Graaf, Winette T A ^a   Stalmeier, Peep F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VIECURI MEDICAL CENTER   (Netherlands)

^c ISALA HOSPITAL   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Breast cancer; Colorectal cancer; Decision aids; Information preference; Palliative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; BREAST TUMOR; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED STUDY; DECISION MAKING; DECISION SUPPORT SYSTEM; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MIDDLE AGED; MULTICENTER STUDY; ONCOLOGIST; PALLIATIVE THERAPY; PATIENT PREFERENCE; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; COMMUNICATION; DECISION MAKING; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; ONCOLOGISTS; PALLIATIVE CARE; PATIENT PREFERENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84929692956     PISSN: 08858195     EISSN: 15430154     Source Type: Journal    
DOI: 10.1007/s13187-015-0845-9     Document Type: Article

References (25)

1. Blinman P, King M, Norman R, Viney R, Stockler MR (2012) Preferences for cancer treatments: an overview of methods and applications in oncology. Ann Oncol 23(5):1104–1110. doi:10.1093/annonc/mdr559
2. Elit L, Charles C, Gafni A, Ranford J, Gold ST, Gold I (2012) Walking a tightrope: oncologists’ perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter. Support Care Cancer 20(10):2327–2333. doi:10.1007/s00520-011-1344-0
3. Gaston CM, Mitchell G (2005) Information giving and decision-making in patients with advanced cancer: a systematic review. Soc Sci Med 61(10):2252–2264. doi:10.1016/j.socscimed.2005.04.015
4. Barnett MM (2006) Does it hurt to know the worst?—psychological morbidity, information preferences and understanding of prognosis in patients with advanced cancer. Psychooncology 15(1):44–55. doi:10.1002/pon.921
5. Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D (2007) Desire for information and involvement in treatment decisions: elderly cancer patients’ preferences and their physicians’ perceptions. J Clin Oncol 25(33):5275–5280. doi:10.1200/JCO.2007.11.1922
6. Bruera E, Sweeney C, Calder K, Palmer L, Benisch-Tolley S (2001) Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol 19(11):2883–2885
7. Rothenbacher D, Lutz MP, Porzsolt F (1997) Treatment decisions in palliative cancer care: patients’ preferences for involvement and doctors’ knowledge about it. Eur J Cancer 33(8):1184–1189
8. Stalmeier PF, van Tol-Geerdink JJ, van Lin EN, Schimmel E, Huizenga H, van Daal WA, Leer JW (2007) Doctors’ and patients’ preferences for participation and treatment in curative prostate cancer radiotherapy. J Clin Oncol 25(21):3096–3100. doi:10.1200/JCO.2006.07.4955
9. Sepucha KR, Ozanne EM, Partridge AH, Moy B (2009) Is there a role for decision aids in advanced breast cancer? Med Decis Mak 29(4):475–482. doi:10.1177/0272989X09333124
10. Mulley AG, Trimble C, Elwyn G (2012) Stop the silent misdiagnosis: patients’ preferences matter. BMJ 345:e6572. doi:10.1136/bmj.e6572
11. Oostendorp LJ, Ottevanger PB, van der Graaf WT, Stalmeier PF (2011) Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol. BMC Med Inf Decis Making 11:9. doi:10.1186/1472-6947-11-9
12. Oostendorp LJ, Stalmeier PF, Pasker-de Jong PC, Van der Graaf WT, Ottevanger PB (2010) Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer. Anti-Cancer Drugs 21(8):749–758. doi:10.1097/CAD.0b013e32833c57cf
13. Oostendorp LJ, Stalmeier PF, Donders AR, van der Graaf WT, Ottevanger PB (2011) Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review. Lancet Oncol 12(11):1053–1061. doi:10.1016/S1470-2045(11)70045-6
14. Cicchetti DV, Feinstein AR (1990) High agreement but low kappa: II. Resolving the paradoxes. J Clin Epidemiol 43(6):551–558
15. Koedoot CG, Oort FJ, de Haan RJ, Bakker PJ, de Graeff A, de Haes JC (2004) The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are: palliative chemotherapy and watchful-waiting. Eur J Cancer 40(2):225–235
16. Hagerty RG, Butow PN, Ellis PM, Dimitry S, Tattersall MH (2005) Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol: Off J Eur Soc Med Oncol / ESMO 16(7):1005–1053. doi:10.1093/annonc/mdi211
17. Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, Schrag D (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367(17):1616–1625. doi:10.1056/NEJMoa1204410
18. Hancock K, Clayton JM, Parker SM, Wal der S, Butow PN, Carrick S, Currow D et al (2007) Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med 21(6):507–517. doi:10.1177/0269216307080823
19. Cripe LD, Rawl SM, Schmidt KK, Tong Y, Monahan PO, Rand KL (2012) Discussions of life expectancy moderate relationships between prognosis and anxiety or depression in men with advanced cancer. J Palliat Med 15(1):99–105. doi:10.1089/jpm.2011.0249
20. Smith TJ, Dow LA, Virago E, Khatcheressian J, Lyckholm LJ, Matsuyama R (2010) Giving honest information to patients with advanced cancer maintains hope. Oncology (Williston Park) 24(6):521–525
21. Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T, Mitchell SL et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300(14):1665–1673. doi:10.1001/jama.300.14.1665
22. Fallowfield LJ, Jenkins VA, Beveridge HA (2002) Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med 16(4):297–303
23. Clayton JM, Hancock KM, Butow PN, Tattersall MH, Currow DC (2007) Clinical practice guidelines for communicating prognosis and end-of-life issues with adults in the advanced stages of a life-limiting illness, and their caregivers. Med J Aust 186(12 Suppl):S77–108
24. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Legare F, Thomson R (2011) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. CD001431. doi: 10.1002/14651858.Cd001431.Pub3
25. Smith TJ, Longo DL (2012) Talking with patients about dying. N Engl J Med 367(17):1651–1652. doi:10.1056/NEJMe1211160